Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorUyarel, Hüseyin
dc.contributor.authorErgelen, Mehmet
dc.contributor.authorÇiçek, Gökhan
dc.contributor.authorKaya, Mehmet Güngör
dc.contributor.authorAyhan, Erkan
dc.contributor.authorTürkkan, Ceyhan
dc.contributor.authorYıldırım, Ersin
dc.contributor.authorKırbaş, Veli
dc.date.accessioned2019-10-16T11:44:18Z
dc.date.available2019-10-16T11:44:18Z
dc.date.issued2011en_US
dc.identifier.issn0954-6928
dc.identifier.issneISSN: 1473-5830
dc.identifier.urihttps://doi.org/ 10.1097/MCA.0b013e328342c77b
dc.identifier.urihttps://hdl.handle.net/20.500.12462/7192
dc.descriptionUyarel, Hüseyin (Balikesir Author)en_US
dc.description.abstractObjectives Red cell distribution width (RDW), a measure of red blood cell size heterogeneity, was evaluated in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI). Background Higher RDW is associated with mortality in patients with symptomatic cardiovascular disease, heart failure, and also in the general population. We hypothesized that admission RDW would be predictive of adverse outcomes in patients after primary PCI. Methods Two thousand five hundred and six consecutive STEMI patients (mean age 56.6 +/- 11.8 years; 2075 males, 431 females) undergoing primary PCI were retrospectively enrolled into this study. Admission RDW was measured as part of the automated complete blood count. Patients were grouped as elevated or nonelevated RDW using the upper limit of normal value of 14.8% and were followed for in-hospital and long-term outcomes for a mean period of 1.8 +/- 1.3 years (median 21 months). Results A higher in-hospital mortality rate was observed among patients with elevated admission RDW (mean 16.1 +/- 1.6%) compared with those with nonelevated RDW (mean 13.4 +/- 0.8%) (7.6 vs. 3.6%, P < 0.001). The long-term cardiovascular prognosis was worse for patients with elevated admission RDW (Kaplan-Meier, log-rank P<0.001). We used Cox proportional hazard models to examine the association between RDW and adverse clinical outcomes. After discharge, there were 129 deaths during follow-up. A significant association was noted between elevated admission RDW level and the adjusted risk of cardiovascular mortality (hazard ratio: 1.831, 95% confidence interval: 1.034-3.24, P = 0.03). In addition, elevated admission RDW was also an independent predictor of cardiovascular mortality in the nonanemic subpopulation of patients (hazard ratio: 2.703, 95% confidence interval: 1.208-6.048, P = 0.016). Conclusion A high admission RDW level in patients with STEMI undergoing primary PCI was associated with increased risk for in-hospital and long-term cardiovascular mortality.en_US
dc.language.isoengen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.isversionof10.1097/MCA.0b013e328342c77ben_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAcute Myocardial Infarctionen_US
dc.subjectPrimary Angioplastyen_US
dc.subjectRed Cell Distribution Widthen_US
dc.titleRed cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarctionen_US
dc.typearticleen_US
dc.relation.journalCoronary Artery Diseaseen_US
dc.contributor.departmentTıp Fakültesien_US
dc.identifier.volume22en_US
dc.identifier.issue3en_US
dc.identifier.startpage138en_US
dc.identifier.endpage144en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster